{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:1eda4411-861d-4b32-822e-31a7f2a1e680","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-21T09:10:41.946236+00:00","published_at":"2026-10-21T04:45:57.245858+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:mhod6n1s9qdat","event_type":"CFO_CHANGED","effective_at":"2026-02-26","detected_at":"2026-10-21T04:45:57.245858+00:00","subject_ids":["alpha:person:joseph-miller-auph","alpha:company:1eda4411-861d-4b32-822e-31a7f2a1e680"],"caused_claim_ids":["alpha:claim:company:1eda4411-861d-4b32-822e-31a7f2a1e680:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:1599c4103a81c360e538ab6c6e13f0d1017a674629489b36c97ea78d26b8cbcc"],"summary":"Joseph Miller executive of Aurinia Pharmaceuticals Inc., effective 2026-02-26.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:oaryjw8dn24g","event_type":"CEO_CHANGED","effective_at":"2026-02-26","detected_at":"2026-10-21T04:45:57.245858+00:00","subject_ids":["alpha:person:peter-greenleaf-auph","alpha:company:1eda4411-861d-4b32-822e-31a7f2a1e680"],"caused_claim_ids":["alpha:claim:company:1eda4411-861d-4b32-822e-31a7f2a1e680:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:64d36858256706a4f874c5becafdb2d1150d53366e2eec998dbc51d7f564a4fc"],"summary":"Peter Greenleaf executive of Aurinia Pharmaceuticals Inc., effective 2026-02-26.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:15rejrvdmbbz3","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-21T04:45:57.245858+00:00","subject_ids":["alpha:person:kathy-goetz","alpha:company:1eda4411-861d-4b32-822e-31a7f2a1e680"],"caused_claim_ids":["alpha:claim:company:1eda4411-861d-4b32-822e-31a7f2a1e680:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:5694571672e7bf84613c2fd02c9aa2507ce0818243c908cb0960b2bb01f66492"],"summary":"Kathy Goetz seat on Aurinia Pharmaceuticals Inc., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:meddsjq65s4d","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-21T04:45:57.245858+00:00","subject_ids":["alpha:person:tina-s-nova-ph-d","alpha:company:1eda4411-861d-4b32-822e-31a7f2a1e680"],"caused_claim_ids":["alpha:claim:company:1eda4411-861d-4b32-822e-31a7f2a1e680:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:5694571672e7bf84613c2fd02c9aa2507ce0818243c908cb0960b2bb01f66492"],"summary":"Tina S. Nova, Ph.D. seat on Aurinia Pharmaceuticals Inc., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1ju1b9z4hwduf","event_type":"COMMITTEE_CREATED","effective_at":"2025-01-01","detected_at":"2026-10-21T04:45:57.245858+00:00","subject_ids":["alpha:committee:aurinia-pharmaceuticals-inc:audit-compensation","alpha:company:1eda4411-861d-4b32-822e-31a7f2a1e680"],"caused_claim_ids":["alpha:claim:company:1eda4411-861d-4b32-822e-31a7f2a1e680:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:5694571672e7bf84613c2fd02c9aa2507ce0818243c908cb0960b2bb01f66492"],"summary":"Audit; Compensation committee of Aurinia Pharmaceuticals Inc., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:fa02cxlwyj75","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2025-01-01","detected_at":"2026-10-21T04:45:57.245858+00:00","subject_ids":["alpha:person:kathy-goetz","alpha:committee:aurinia-pharmaceuticals-inc:audit-compensation"],"caused_claim_ids":["alpha:claim:company:1eda4411-861d-4b32-822e-31a7f2a1e680:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:5694571672e7bf84613c2fd02c9aa2507ce0818243c908cb0960b2bb01f66492"],"summary":"Kathy Goetz member of Audit; Compensation, effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:ru7pb8hcltd8","event_type":"DIRECTOR_APPOINTED","effective_at":"2024-01-01","detected_at":"2026-10-21T04:45:57.245858+00:00","subject_ids":["alpha:person:craig-johnson","alpha:company:1eda4411-861d-4b32-822e-31a7f2a1e680"],"caused_claim_ids":["alpha:claim:company:1eda4411-861d-4b32-822e-31a7f2a1e680:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:5694571672e7bf84613c2fd02c9aa2507ce0818243c908cb0960b2bb01f66492"],"summary":"Craig Johnson seat on Aurinia Pharmaceuticals Inc., effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:191nj9195olyp","event_type":"DIRECTOR_APPOINTED","effective_at":"2024-01-01","detected_at":"2026-10-21T04:45:57.245858+00:00","subject_ids":["alpha:person:kevin-tang","alpha:company:1eda4411-861d-4b32-822e-31a7f2a1e680"],"caused_claim_ids":["alpha:claim:company:1eda4411-861d-4b32-822e-31a7f2a1e680:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:5694571672e7bf84613c2fd02c9aa2507ce0818243c908cb0960b2bb01f66492"],"summary":"Kevin Tang seat on Aurinia Pharmaceuticals Inc., effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:76qkby15twheo","event_type":"COMMITTEE_CREATED","effective_at":"2024-01-01","detected_at":"2026-10-21T04:45:57.245858+00:00","subject_ids":["alpha:committee:aurinia-pharmaceuticals-inc:audit-chair-compensation-chair","alpha:company:1eda4411-861d-4b32-822e-31a7f2a1e680"],"caused_claim_ids":["alpha:claim:company:1eda4411-861d-4b32-822e-31a7f2a1e680:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:5694571672e7bf84613c2fd02c9aa2507ce0818243c908cb0960b2bb01f66492"],"summary":"Audit · Chair; Compensation · Chair committee of Aurinia Pharmaceuticals Inc., effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:spyjumm1xfa2","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2024-01-01","detected_at":"2026-10-21T04:45:57.245858+00:00","subject_ids":["alpha:person:craig-johnson","alpha:committee:aurinia-pharmaceuticals-inc:audit-chair-compensation-chair"],"caused_claim_ids":["alpha:claim:company:1eda4411-861d-4b32-822e-31a7f2a1e680:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:5694571672e7bf84613c2fd02c9aa2507ce0818243c908cb0960b2bb01f66492"],"summary":"Craig Johnson member of Audit · Chair; Compensation · Chair, effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:7jw77cni92v4","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-10-21T04:45:57.245858+00:00","subject_ids":["alpha:person:jeffrey-bailey","alpha:company:1eda4411-861d-4b32-822e-31a7f2a1e680"],"caused_claim_ids":["alpha:claim:company:1eda4411-861d-4b32-822e-31a7f2a1e680:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:5694571672e7bf84613c2fd02c9aa2507ce0818243c908cb0960b2bb01f66492"],"summary":"Jeffrey Bailey seat on Aurinia Pharmaceuticals Inc., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:ooifew1mb1vgg","event_type":"COMMITTEE_CREATED","effective_at":"2023-01-01","detected_at":"2026-10-21T04:45:57.245858+00:00","subject_ids":["alpha:committee:aurinia-pharmaceuticals-inc:audit-compensation-nominating-and-governance-chair","alpha:company:1eda4411-861d-4b32-822e-31a7f2a1e680"],"caused_claim_ids":["alpha:claim:company:1eda4411-861d-4b32-822e-31a7f2a1e680:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:5694571672e7bf84613c2fd02c9aa2507ce0818243c908cb0960b2bb01f66492"],"summary":"Audit; Compensation; Nominating and Governance · Chair committee of Aurinia Pharmaceuticals Inc., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1ob77x61xesvsw","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2023-01-01","detected_at":"2026-10-21T04:45:57.245858+00:00","subject_ids":["alpha:person:jeffrey-bailey","alpha:committee:aurinia-pharmaceuticals-inc:audit-compensation-nominating-and-governance-chair"],"caused_claim_ids":["alpha:claim:company:1eda4411-861d-4b32-822e-31a7f2a1e680:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:5694571672e7bf84613c2fd02c9aa2507ce0818243c908cb0960b2bb01f66492"],"summary":"Jeffrey Bailey member of Audit; Compensation; Nominating and Governance · Chair, effective 2023-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:1eda4411-861d-4b32-822e-31a7f2a1e680:leadership_role:5","subject_id":"alpha:company:1eda4411-861d-4b32-822e-31a7f2a1e680","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:craig-johnson","object_label":"Craig Johnson","object_source_name_forms":[],"value":"Craig Johnson: Director, Audit · Chair; Compensation · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:craig-johnson","name":"Craig Johnson"},"title":"Director","role_category":"director","committee":"Audit · Chair; Compensation · Chair","is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-21T04:45:57.245858+00:00","sources":[{"id":"alpha:projection-evidence:document:5694571672e7bf84613c2fd02c9aa2507ce0818243c908cb0960b2bb01f66492","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Aurinia Pharmaceuticals Inc. DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062026000039/auph-20260421.htm","source_date":"2026-04-21","retrieved_at":"2026-04-24T15:50:02.471+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-21T04:45:57.245858+00:00","reviewed_at":"2026-10-21T04:45:57.245858+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1eda4411-861d-4b32-822e-31a7f2a1e680:leadership_role:6","subject_id":"alpha:company:1eda4411-861d-4b32-822e-31a7f2a1e680","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:jeffrey-bailey","object_label":"Jeffrey Bailey","object_source_name_forms":[],"value":"Jeffrey Bailey: Director, Audit; Compensation; Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:jeffrey-bailey","name":"Jeffrey Bailey"},"title":"Director","role_category":"director","committee":"Audit; Compensation; Nominating and Governance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-21T04:45:57.245858+00:00","sources":[{"id":"alpha:projection-evidence:document:5694571672e7bf84613c2fd02c9aa2507ce0818243c908cb0960b2bb01f66492","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Aurinia Pharmaceuticals Inc. DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062026000039/auph-20260421.htm","source_date":"2026-04-21","retrieved_at":"2026-04-24T15:50:02.471+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-21T04:45:57.245858+00:00","reviewed_at":"2026-10-21T04:45:57.245858+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1eda4411-861d-4b32-822e-31a7f2a1e680:leadership_role:7","subject_id":"alpha:company:1eda4411-861d-4b32-822e-31a7f2a1e680","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:kathy-goetz","object_label":"Kathy Goetz","object_source_name_forms":[],"value":"Kathy Goetz: Director, Audit; Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:kathy-goetz","name":"Kathy Goetz"},"title":"Director","role_category":"director","committee":"Audit; Compensation","is_board_chair":false,"is_independent":true,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-21T04:45:57.245858+00:00","sources":[{"id":"alpha:projection-evidence:document:5694571672e7bf84613c2fd02c9aa2507ce0818243c908cb0960b2bb01f66492","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Aurinia Pharmaceuticals Inc. DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062026000039/auph-20260421.htm","source_date":"2026-04-21","retrieved_at":"2026-04-24T15:50:02.471+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-21T04:45:57.245858+00:00","reviewed_at":"2026-10-21T04:45:57.245858+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1eda4411-861d-4b32-822e-31a7f2a1e680:leadership_role:8","subject_id":"alpha:company:1eda4411-861d-4b32-822e-31a7f2a1e680","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:kevin-tang","object_label":"Kevin Tang","object_source_name_forms":[],"value":"Kevin Tang: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:kevin-tang","name":"Kevin Tang"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-21T04:45:57.245858+00:00","sources":[{"id":"alpha:projection-evidence:document:5694571672e7bf84613c2fd02c9aa2507ce0818243c908cb0960b2bb01f66492","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Aurinia Pharmaceuticals Inc. DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062026000039/auph-20260421.htm","source_date":"2026-04-21","retrieved_at":"2026-04-24T15:50:02.471+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-21T04:45:57.245858+00:00","reviewed_at":"2026-10-21T04:45:57.245858+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1eda4411-861d-4b32-822e-31a7f2a1e680:leadership_role:9","subject_id":"alpha:company:1eda4411-861d-4b32-822e-31a7f2a1e680","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:tina-s-nova-ph-d","object_label":"Tina S. Nova, Ph.D.","object_source_name_forms":[],"value":"Tina S. Nova, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:tina-s-nova-ph-d","name":"Tina S. Nova, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-21T04:45:57.245858+00:00","sources":[{"id":"alpha:projection-evidence:document:5694571672e7bf84613c2fd02c9aa2507ce0818243c908cb0960b2bb01f66492","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Aurinia Pharmaceuticals Inc. DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062026000039/auph-20260421.htm","source_date":"2026-04-21","retrieved_at":"2026-04-24T15:50:02.471+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-21T04:45:57.245858+00:00","reviewed_at":"2026-10-21T04:45:57.245858+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1eda4411-861d-4b32-822e-31a7f2a1e680:leadership_role:10","subject_id":"alpha:company:1eda4411-861d-4b32-822e-31a7f2a1e680","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:joseph-miller-auph","object_label":"Joseph Miller","object_source_name_forms":[],"value":"Joseph Miller: Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:joseph-miller-auph","name":"Joseph Miller"},"title":"Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-02-26","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-02-26","valid_to":null,"recorded_at":"2026-10-21T04:45:57.245858+00:00","sources":[{"id":"alpha:projection-evidence:document:1599c4103a81c360e538ab6c6e13f0d1017a674629489b36c97ea78d26b8cbcc","identity_scope":"source_document_reference","source_type":"sec_filing","title":"AUPH 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062026000017/auph-20251231.htm","source_date":"2026-02-26T00:00:00+00:00","retrieved_at":"2026-05-14T23:45:42.325533+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-02-26T00:00:00+00:00","effective_from":"2026-02-26","effective_until":null,"observed_at":"2026-10-21T04:45:57.245858+00:00","reviewed_at":"2026-10-21T04:45:57.245858+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1eda4411-861d-4b32-822e-31a7f2a1e680:leadership_role:11","subject_id":"alpha:company:1eda4411-861d-4b32-822e-31a7f2a1e680","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:peter-greenleaf-auph","object_label":"Peter Greenleaf","object_source_name_forms":[],"value":"Peter Greenleaf: President, Chief Executive Officer, Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:peter-greenleaf-auph","name":"Peter Greenleaf"},"title":"President, Chief Executive Officer, Director","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-02-26","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-02-26","valid_to":null,"recorded_at":"2026-10-21T04:45:57.245858+00:00","sources":[{"id":"alpha:projection-evidence:document:64d36858256706a4f874c5becafdb2d1150d53366e2eec998dbc51d7f564a4fc","identity_scope":"source_document_reference","source_type":"sec_filing","title":"AUPH 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062026000017/auph-20251231.htm","source_date":"2026-02-26T00:00:00+00:00","retrieved_at":"2026-05-14T23:45:41.87104+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-02-26T00:00:00+00:00","effective_from":"2026-02-26","effective_until":null,"observed_at":"2026-10-21T04:45:57.245858+00:00","reviewed_at":"2026-10-21T04:45:57.245858+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:5694571672e7bf84613c2fd02c9aa2507ce0818243c908cb0960b2bb01f66492","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Aurinia Pharmaceuticals Inc. DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062026000039/auph-20260421.htm","source_date":"2026-04-21","retrieved_at":"2026-04-24T15:50:02.471+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:1599c4103a81c360e538ab6c6e13f0d1017a674629489b36c97ea78d26b8cbcc","identity_scope":"source_document_reference","source_type":"sec_filing","title":"AUPH 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062026000017/auph-20251231.htm","source_date":"2026-02-26T00:00:00+00:00","retrieved_at":"2026-05-14T23:45:42.325533+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:64d36858256706a4f874c5becafdb2d1150d53366e2eec998dbc51d7f564a4fc","identity_scope":"source_document_reference","source_type":"sec_filing","title":"AUPH 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062026000017/auph-20251231.htm","source_date":"2026-02-26T00:00:00+00:00","retrieved_at":"2026-05-14T23:45:41.87104+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.831,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.876,"cross_source_agreement":0.75,"temporal_completeness":0.5},"diagnostics":{"published_claims":21,"factual_claims":21,"claims_with_linked_evidence":21,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":14,"temporal_claims_with_valid_from":7,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-21T04:45:57.245858+00:00","observed_at":"2026-10-21T04:45:57.245858+00:00","reviewed_at":"2026-10-21T04:45:57.245858+00:00","verified_at":"2026-10-21T04:45:57.245858+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":21,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/aurinia-pharmaceuticals-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/aurinia-pharmaceuticals-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}